A simple blood test can detect 50 types of cancer

But scientists are conducting a new test that can revolutionize diagnosis: a blood test that can detect up to 50 different types of cancer, long before symptoms appear, has reported U n SA Today.

What's the MCED Galler test?

This test known as Galler M CED (Multi-Cancer Early Development) is a type of liquid biopsy intended to identify blood cancer signs in earlier stages.

He works by analyzing DNA and proteins that circulate in the blood, which can tell whether a tumor is developing somewhere in the body. Through the algorithms of artificial intelligence and machine learning, the test also tries to determine the possible location of body cancer.

The goal is to catch cancer before giving any clinical signs to”, researchers working with this method explain.

How does the liquid “biopsia” work?

After taking a blood sample, the lab analyzes DNA with very advanced technology. If anomalies are discovered, they are studied more carefully to see if they are related to any type of cancer.
This molecular analysis, combined with computer classifications, shows great potential for identifying origin tissue and revealing many other types of cancer.

With this molecular data, the doctor can propose more objective and more effective treatments,” is said in the scientific summary of the study.

Is the test already approved?

According to the US National Institute of Health (NIH), no MCED test has yet to be adopted by the FDA (American Food and Bars Administration). Some versions are available only as tests conducted in private labs, but have not yet received official authorization for extensive use.

However, The FDA has given several MCED status tests “Breacthrightthrough Device Desigation”, which means that their development and assessment process is accelerating due to the great potential in saving lives. This status does not imply approval, but it is an important step toward it./Periscopi/